Menu
Recruiting NCT03577327

The Gut and Skin Microbiome in Vitiligo Disease Progression

Observational Vitiligo Healthy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Vitiligo, Healthy. Basic parameters: 18 years — 89 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.

Primary outcome measures

  • Microbiome composition [Time frame: 12 months]
  • Disease Progression [Time frame: 12 months]
Secondary outcome measures (1)
  • Diet History Food Frequencies [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • Patients with and/or without vitiligo lesional expansion over the past year.
  • Age/sex-matched controls who do not have a diagnosis of vitiligo
  • Subjects who are age 18-89 years of age at time of enrollment
  • Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)

Exclusion criteria

  • Subjects who are younger than 18 years of age or 90 years of age or older
  • Subjects who are unable to give consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Northwestern University — Chicago

Identifiers

NCT: NCT03577327 · ICLP10302017

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗